Granules India Limited — Updates, 12-12-2025: General Updates
12-12-2025 | 03:12 pm
12-12-2025 | 03:12 pm
Granules Life Sciences (subsidiary) received a US FDA Establishment Inspection Report (EIR), confirming its Hyderabad facility meets FDA quality standards. This is crucial for its PFI & Finished Dosages production for the US market.